Gatti M.; Fusaroli M.; Raschi E.; Moretti U.; Poluzzi E.; De Ponti F., Serious adverse events with tedizolid and linezolid: pharmacovigilance insights through the FDA adverse event reporting system, «EXPERT OPINION ON DRUG SAFETY», 2021, 20, pp. 1421 - 1431 [Scientific article]
Gatti, M.; Fusaroli, M.; Caraceni, P.; Poluzzi, E.; De Ponti, F.; Raschi, E., Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID-19, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2021, 87, pp. 1533 - 1540 [Scientific article]Open Access
Raschi E.; Fadini G.P.; Diemberger I.; Poluzzi E.; De Ponti F., SGLT2 inhibitors for heart failure with reduced ejection fraction: a real EMPEROR?, «EXPERT OPINION ON PHARMACOTHERAPY», 2021, 22, pp. 647 - 650 [Scientific article]
Dika, Emi; Mastroeni, Simona; Lambertini, Martina; Scarfì, Federica; Patrizi, Annalisa; Veronesi, Giulia; Magnaterra, Elisabetta; Borghi, Alessandro; Corazza, Monica; Diemberger, Igor; Poluzzi, Elisabetta; Fortes, Cristina, The chronic use of multiple photosensitizing drugs is associated with Breslow thickness in female melanoma patients: A bicentric retrospective study, «JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY», 2021, 84, pp. 1762 - 1764 [Scientific article]
Raschi E.; La Placa M.; Poluzzi E.; De Ponti F., The value of case reports and spontaneous reporting systems for pharmacovigilance and clinical practice, «BRITISH JOURNAL OF DERMATOLOGY», 2021, 184, pp. 581 - 583 [Scientific article]Open Access
Raschi, Emanuel; Fusaroli, Michele; Ardizzoni, Andrea; Poluzzi, Elisabetta; De Ponti, Fabrizio, Thromboembolic Events with Cyclin-Dependent Kinase 4/6 Inhibitors in the FDA Adverse Event Reporting System, «CANCERS», 2021, 13, Article number: 1758 , pp. 1 - 12 [Scientific article]Open Access
Raschi E.; Caraceni P.; Poluzzi E.; De Ponti F., Baricitinib, JAK inhibitors and liver injury: a cause for concern in COVID-19?, «EXPERT OPINION ON DRUG SAFETY», 2020, 19, pp. 1367 - 1369 [Comment or similar]
Capelli, Irene; Vitali, Francesca; Zappulo, Fulvia; Martini, Silvia; Donadei, Chiara; Cappuccilli, Maria; Leonardi, Luca; Girardi, Anna; Aiello, Valeria; Galletti, Silvia; Faldella, Giacomo; Poluzzi, Elisabetta; DE Ponti, Fabrizio; LA MANNA, Gaetano, Biomarkers of Kidney Injury in Very-low-birth-weight Preterm Infants: Influence of Maternal and Neonatal Factors, «IN VIVO», 2020, 34, pp. 1333 - 1339 [Scientific article]Open Access
Frega G.; Palloni A.; Di Pasquale G.; Saccoccio G.; Rizzo A.; Poluzzi E.; Iannone P.; Brandi G., Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements, «FRONTIERS IN PHARMACOLOGY», 2020, 11, Article number: 559996 , pp. 1 - 6 [Scientific article]Open Access
Raschi E.; Fusaroli M.; Diemberger I.; Poluzzi E., Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance, «DRUG SAFETY», 2020, 43, pp. 1191 - 1194 [Scientific article]
Raschi E.; Gatti M.; Gelsomino F.; Ardizzoni A.; Poluzzi E.; De Ponti F., Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance, «TARGETED ONCOLOGY», 2020, 15, pp. 449 - 466 [Scientific article]Open Access
Gatti M.; Poluzzi E.; De Ponti F.; Raschi E., Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis, «DRUG SAFETY», 2020, 43, pp. 1277 - 1285 [Scientific article]Open Access
Iommi M.; Rosa S.; Fusaroli M.; Rucci P.; Fantini M.P.; Poluzzi E., Modified-Chronic Disease Score (M-CDS): Predicting the individual risk of death using drug prescriptions, «PLOS ONE», 2020, 15, Article number: e0240899 , pp. 1 - 13 [Scientific article]Open Access
Antonazzo I.C.; Poluzzi E.; Forcesi E.; Salvo F.; Pariente A.; Marchesini G.; De Ponti F.; Raschi E., Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system, «ACTA DIABETOLOGICA», 2020, 57, pp. 71 - 80 [Scientific article]
Lunghi C.; Antonazzo I.C.; Burato S.; Raschi E.; Zoffoli V.; Forcesi E.; Sangiorgi E.; Menchetti M.; Roberge P.; Poluzzi E., Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study, «NEUROPSYCHIATRIC DISEASE AND TREATMENT», 2020, 16, pp. 1157 - 1170 [Scientific article]Open Access
